Emerging from stealth mode on April 29, 2025, IXI's funding round was led by London-based VC firm Plural, with notable participation from the Amazon Alexa Fund and other investors, highlighting significant interest in the smart eyewear market.

IXI has filed 12 patents and has around 50 additional applications pending, underscoring the importance of its intellectual property in maintaining a competitive edge.

The funds will be allocated towards product development, testing, and preparing for market launch, targeting both consumers and healthcare providers.

The glasses are designed to improve convenience for users who currently rely on multiple pairs of spectacles, eliminating the need for bulky varifocal lenses.

IXI claims that the glasses will feature a battery life of approximately two days, with a basic lens prescription ensuring clear distance vision even if the battery fails.

Niko Eiden, co-founder and CEO, emphasized the need for innovation in eyewear technology, stating that their glasses represent the future of optical science and aim to redefine vision correction.

With an aging global population, IXI addresses the growing issue of presbyopia, which affects many individuals' vision as they age, and aims to create glasses that function as medical devices rather than just offering smart features.

The company's glasses will automatically adjust focus based on individual prescriptions, enhancing vision correction and providing a seamless transition between viewing distances.

Investors, including representatives from the Amazon Alexa Fund, expressed enthusiasm for IXI's innovative approach to on-demand vision correction, marking a significant step in eyewear technology.

IXI's glasses are designed to allow for a wider field of vision and seamless transitions between viewing distances, mimicking the natural vision of younger individuals.

IXI, a Finnish startup founded in 2021 by Niko Eiden and Ville Miettinen, has successfully raised $36.5 million to develop innovative autofocus prescription glasses that utilize eye-tracking and liquid crystal lens technology.

The company's groundbreaking technology aims to enhance vision without the drawbacks of traditional eyewear, such as limited fields of view and peripheral distortion, addressing common vision challenges like presbyopia.